Isolated pancreatic metastasis is a rare occurrence and is commonly misdiagnosed as primary pancreatic malignancy. We present a case of a 65-year-old female patient with a history of stage IIIA lung adenocarcinoma, who developed significant epigastric pain 27 months after diagnosis and treatment of a primary lung adenocarcinoma. This patient was found to have a pancreatic head lesion initially suspected to be a primary pancreatic neoplasm but eventually discovered to be a metastatic lesion from the previously treated primary lung adenocarcinoma.

Faculty of Medicine Masaryk University Brno Czech Republic

Geisinger Wyoming Valley Medical Center Hematology and Medical Oncology Department Wilkes Barre PA USA

Geisinger Wyoming Valley Medical Center Internal Medicine Department Wilkes Barre PA USA

Geisinger Wyoming Valley Medical Center Pathology and Laboratory Medicine Wilkes Barre PA USA

Zobrazit více v PubMed

Hendriks LE, Kerr KM, Menis J, Mok TS, Nestle U, Passaro A, et al. . Oncogene-addicted metastatic non-small-cell lung cancer: ESMO clinical practice guideline for diagnosis, treatment and follow-up. Ann Oncol. 2023;34(4):339–57. 10.1016/j.annonc.2022.12.009. PubMed DOI

National Comprehensive Cancer Network (NCCN) . Clinical practice guidelines in oncology. Non-small cell lung cancer version 3.2023: April 13. 2023. https://www.nccn.org/professionals/physician_gls/pdf/nscl.pdf (accessed 13 June 2023).

Li J, He Q, Yu X, Khan K, Weng X, Guan M. Complete response associated with immune checkpoint inhibitors in advanced non-small-cell lung cancer: a meta-analysis of nine randomized controlled trials. Cancer Manag Res. 2019;11:1623–9. 10.2147/CMAR.S188551. PubMed DOI PMC

Santoni M, Rizzo A, Kucharz J, Mollica V, Rosellini M, Marchetti A, et al. . Complete remissions following immunotherapy or immuno-oncology combinations in cancer patients: the MOUSEION-03 meta-analysis. Cancer Immunol Immunother. 2023;72(6):1365–79. 10.1007/s00262-022-03349-4. PubMed DOI PMC

Reck M, Rodríguez-Abreu D, Robinson AG, Hui R, Csőszi T, Fülöp A, et al. . Updated analysis of KEYNOTE-024: pembrolizumab versus platinum-based chemotherapy for advanced non-small-cell lung cancer with PD-L1 tumor proportion score of 50% or greater. J Clin Oncol. 2019;37(7):537–46. 10.1200/JCO.18.00149. PubMed DOI

Peng L, Liang WH, Mu DG, Xu S, Hong SD, Stebbing J, et al. . First-line treatment options for PD-L1-negative non-small cell lung cancer: a bayesian network meta-analysis. Front Oncol. 2021;11:657545. PubMed PMC

Winer A, Bodor JN, Borghaei H. Identifying and managing the adverse effects of immune checkpoint blockade. J Thorac Dis. 2018 Feb;10(Suppl 3):S480–9. PubMed PMC

Myers G. Immune-related adverse events of immune checkpoint inhibitors: a brief review. Curr Oncol. 2018;25(5):342–7. PubMed PMC

Beckles MA, Spiro SG, Colice GL, Rudd RM. Initial evaluation of the patient with lung cancer: symptoms, signs, laboratory tests, and paraneoplastic syndromes. Chest. 2003;123(1 Suppl l):97S–104S. 10.1378/chest.123.1_suppl.97s. PubMed DOI

Singh D, Vaidya OU, Sadeddin E, Yousef O. Role of endoscopic ultrasound and endoscopic retrograde cholangiopancreatography in isolated pancreatic metastasis from lung cancer. World J Gastrointest Endosc. 2012;4(7):328–30. 10.4253/wjge.v4.i7.328. PubMed DOI PMC

Adsay NV, Andea A, Basturk O, Kilinc N, Nassar H, Cheng JD. Secondary tumors of the pancreas: an analysis of a surgical and autopsy database and review of the literature. Virchows Arch. 2004;444(6):527–35. 10.1007/s00428-004-0987-3. PubMed DOI

Liratzopoulos N, Efremidou EI, Papageorgiou MS, Romanidis K, Minopoulos GJ, Manolas KJ. Extrahepatic biliary obstruction due to a solitary pancreatic metastasis of squamous cell lung carcinoma. Case report. J Gastrointestin Liver Dis. 2006;15(1):73–5. PubMed

Quint LE, Tummala S, Brisson LJ, Francis IR, Krupnick AS, Kazerooni EA, et al. . Distribution of distant metastases from newly diagnosed non-small cell lung cancer. Ann Thorac Surg. 1996;62(1):246–50. 10.1016/0003-4975(96)00220-2. PubMed DOI

Yoon WJ, Ryu JK, Kim YT, Yoon YB, Kim SW, Kim WH. Clinical features of metastatic tumors of the pancreas in Korea: a single-center study. Gut Liver. 2011;5(1):61–4. 10.5009/gnl.2011.5.1.61. PubMed DOI PMC

Galluzzi S, Payne PM. Bronchial carcinoma: a statistical study of 741 necropsies with special reference to the distribution of blood-borne metastases. Br J Cancer. 1955;9(4):511–27. 10.1038/bjc.1955.53. PubMed DOI PMC

Lankisch PG, Löhr A, Kunze E. Metastasen-induzierte akute Pankreatitis beim Bronchialkarzinom [Acute metastasis-induced pancreatitis in bronchial carcinoma]. Dtsch Med Wochenschr. 2008;112(35):1335–7. 10.1055/s-2008-1068245. PubMed DOI

Gonlugur U, Mirici A, Karaayvaz M. Pancreatic involvement in small cell lung cancer. Radiol Oncol. 2014;48(1):11–9. 10.2478/raon-2013-0022. PubMed DOI PMC

Maeno T, Satoh H, Ishikawa H, Yamashita YT, Naito T, Fujiwara M, et al. . Patterns of pancreatic metastasis from lung cancer. Anticancer Res. 1998;18(4B):2881–4. PubMed

Jereczek B, Jassem J, Karnicka-Młodkowska H, Badzio A, Mos-Antkowiak R, Szczepek B, et al. . Autopsy findings in small cell lung cancer. Neoplasma. 1996;43(2):133–7. PubMed

Seki M, Tsuchiya E, Hori M, Nakagawa K, Ohta H, Ueno M, et al. . Pancreatic metastasis from a lung cancer. Preoperative diagnosis and management. Int J Pancreatol. 1998;24(1):55–9. 10.1007/BF02787532. PubMed DOI

Zerbi A, Pecorelli N. Pancreatic metastases: an increasing clinical entity. World J Gastrointest Surg. 2010;2(8):255–9. 10.4240/wjgs.v2.i8.255. PubMed DOI PMC

Noseda A, Gangji D, Cremer M. Acute pancreatitis as presenting symptom and sole manifestation of small cell lung carcinoma. Dig Dis Sci. 1987;32(3):327–31. 10.1007/BF01297062. PubMed DOI

Moazzam N, Mir A, Potti A. Pancreatic metastasis and extrahepatic biliary obstruction in squamous cell lung carcinoma. Med Oncol. 2002;19(4):273–6. 10.1385/mo:19:4:273. PubMed DOI

Pericleous S, Mukherjee S, Hutchins RR. Lung adenocarcinoma presenting as obstructive jaundice: a case report and review of literature. World J Surg Oncol. 2008;6:120. 10.1186/1477-7819-6-120. PubMed DOI PMC

Perfetti V, Markopoulos K, Maffè GC, Picheo R, Corazza GR. Juxtapapillary pancreatic metastasis with obstructive jaundice as isolated recurrence of lung adenocarcinoma. Dig Liver Dis. 2008;40(3):230–1. 10.1016/j.dld.2007.11.008. PubMed DOI

Mori N, Sawada T, Satoh H, Kawaguchi M, Hara H, Matsushita K. A resected case of solitary pancreatic metastasis from adenocarcinoma of the lung. JOP. 2008;9(6):698–703. PubMed

Jeong IB, Kim SM, Lee TH, Im EH, Huh KC, Kang YW, et al. . Pancreatic metastasis and obstructive jaundice in small cell lung carcinoma. Korean J Intern Med. 2006;21(2):132–5. 10.3904/kjim.2006.21.2.132. PubMed DOI PMC

Igai H, Kamiyoshihara M, Nagashima T, Ohtaki Y, Shimizu K. A resectable pancreatic metastasis from pulmonary adenocarcinoma. Ann Thorac Cardiovasc Surg. 2014;20(3):243–5. 10.5761/atcs.cr.12.02049. PubMed DOI

Z’graggen K, Fernández-del Castillo C, Rattner DW, Sigala H, Warshaw AL. Metastases to the pancreas and their surgical extirpation. Arch Surg. 1998;133(4):413–7; discussion 418-9. 10.1001/archsurg.133.4.413. PubMed DOI

Moussa A, Mitry E, Hammel P, Sauvanet A, Nassif T, Palazzo L, et al. . Pancreatic metastases: a multicentric study of 22 patients. Gastroenterol Clin Biol. 2004;28(10 Pt 1):872–6. 10.1016/s0399-8320(04)95151-2. PubMed DOI

Reddy S, Wolfgang CL. The role of surgery in the management of isolated metastases to the pancreas. Lancet Oncol. 2009;10(3):287–93. 10.1016/S1470-2045(09)70065-8. PubMed DOI

Le Borgne J, Partensky C, Glemain P, Dupas B, de Kerviller B. Pancreaticoduodenectomy for metastatic ampullary and pancreatic tumors. Hepatogastroenterology. 2000;47(32):540–4. PubMed